These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39025286)

  • 1. Functional assessment of CYP3A4 and CYP2C19 genetic polymorphisms on the metabolism of clothianidin invitro.
    Hu Y; Ye Z; Wu H; Chen X; Xia H; Cai JP; Hu GX; Xu RA
    Chem Biol Interact; 2024 Aug; 399():111154. PubMed ID: 39025286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional evaluation of CYP2C19 and CYP3A4 gene polymorphism on ibuprofen metabolism.
    Yuan LJ; Li XY; Ni JH; Wang J; Xu XY; Luo JC; Zhou Q; Hu GX; Cai JP; Qian JC
    Toxicol Appl Pharmacol; 2023 Sep; 475():116653. PubMed ID: 37574146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism.
    Ye Z; Xia H; Hu J; Liu YN; Wang A; Cai JP; Hu GX; Xu RA
    Biomed Pharmacother; 2024 Jun; 175():116421. PubMed ID: 38719708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
    Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX
    Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6.
    Weiss J; Sawa E; Riedel KD; Haefeli WE; Mikus G
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):275-82. PubMed ID: 18516595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and kinetics of microsomal and recombinant equine liver cytochrome P450 enzymes responsible for in vitro metabolism of omeprazole.
    Ferlini Agne G; Somogyi AA; Sykes B; Knych H; Franklin S
    Biochem Pharmacol; 2023 Aug; 214():115635. PubMed ID: 37285945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CYP2C19 variants on methadone metabolism in vitro.
    Lan T; Yuan LJ; Hu XX; Zhou Q; Wang J; Huang XX; Dai DP; Cai JP; Hu GX
    Drug Test Anal; 2017 Apr; 9(4):634-639. PubMed ID: 27199033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evaluation of vandetanib metabolism by CYP3A4 variants and potential drug interactions in vitro.
    Han M; Zhang X; Ye Z; Wang J; Qian J; Hu G; Cai J
    Chem Biol Interact; 2021 Dec; 350():109700. PubMed ID: 34648813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C19 Plays a Major Role in the Hepatic
    Perez-Paramo YX; Watson CJW; Chen G; Lazarus P
    Drug Metab Dispos; 2023 Jan; 51(1):29-37. PubMed ID: 35197312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant CYP3A4 variants and interaction on imatinib metabolism in vitro.
    Chen J; Hu Y; Hu J; Ye Z; Lin Q; Cai JP; Hu GX; Xu RA
    Biomed Pharmacother; 2024 Nov; 180():117511. PubMed ID: 39366029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β-eudesmol in human liver: Reaction phenotyping and enzyme kinetics.
    Muhamad N; Na-Bangchang K
    Pharmacol Res Perspect; 2023 Dec; 11(6):e01149. PubMed ID: 37902256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro.
    Xie SL; Zhu X; Gao N; Lin Q; Chen C; Yang YJ; Cai JP; Hu GX; Xu RA
    Food Chem Toxicol; 2023 Nov; 181():114101. PubMed ID: 37863381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
    Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
    Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional assessment of
    Fang P; Tang PF; Xu RA; Zheng X; Wen J; Bao SS; Cai JP; Hu GX
    Drug Des Devel Ther; 2017; 11():3503-3510. PubMed ID: 29263648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 1A1, 2C9, 2C19, and 3A4 Polymorphisms Account for Interindividual Variability of Toxicological Drug Metabolism in Cynomolgus Macaques.
    Uno Y; Uehara S; Murayama N; Yamazaki H
    Chem Res Toxicol; 2018 Dec; 31(12):1373-1381. PubMed ID: 30412386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro.
    Li YH; Lin QM; Pang NH; Zhang XD; Huang HL; Cai JP; Hu GX
    Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):337-344. PubMed ID: 31058459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine.
    Grün B; Merkel U; Riedel KD; Weiss J; Mikus G
    Br J Clin Pharmacol; 2012 Nov; 74(5):854-63. PubMed ID: 22381043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro.
    Lan T; Ma YQ; Dang YM; Wang CC; Xu RA; Cai JP; Hu GX
    J Psychopharmacol; 2021 Dec; 35(12):1517-1522. PubMed ID: 34702100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional assessment of the effects of CYP3A4 variants on acalabrutinib metabolism in vitro.
    Han M; Qian J; Ye Z; Xu R; Chen D; Xie S; Cai J; Hu G
    Chem Biol Interact; 2021 Aug; 345():109559. PubMed ID: 34153224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4.
    Yoo SE; Yi M; Kim WY; Cho SA; Lee SS; Lee SJ; Shin JG
    Drug Metab Pharmacokinet; 2019 Jun; 34(3):201-208. PubMed ID: 30992242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.